Tools & Calculators
Sector: Pharmaceuticals & Biotechnology
|Large Cap
Anthem Biosciences Ltd.
₹696.90
₹681.60
₹697.95
₹579.15
₹873.50
Markets Today
Historical Performance
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 416.58 | 552.23 | 538.01 | 478.98 | 498.26 |
| Operating Expense | 253.53 | 326.57 | 342.58 | 280.87 | 331.40 |
| Operating Profit | 163.05 | 225.66 | 195.43 | 198.11 | 166.86 |
| Depreciation | 26.75 | 23.92 | 22.61 | 20.99 | 19.50 |
| Interest | 1.13 | 2.23 | 1.61 | 2.10 | 1.78 |
| Tax | 37.98 | 54.87 | 50.60 | 90.28 | 41.91 |
| Net Profit | 112.12 | 198.43 | 148.34 | 122.56 | 127.99 |
Research Type
Equity , Long Term
Buy Range
₹649 - ₹0
Target Price
₹740
Stop Loss
-
Target Date
7 Jan 27
Potential Returns
14.02 %
₹696.90
↗ Bullish Moving Average
13
↘ Bearish Moving Average
0
| Held By | Sep 2025 | Dec 2025 |
|---|---|---|
| Promoter | 74.7 | 74.7 |
| FII | 1.7 | 1.4 |
| DII | 7.2 | 7.6 |
| Public | 16.4 | 16.3 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 43.34 K | 93.15 K | 46.52% |
| Week | 66.05 K | 1.15 L | 57.62% |
| 1 Month | 1.41 L | 2.79 L | 50.78% |
| 6 Month | 2.51 L | 4.69 L | 53.58% |
Positive Breakout First Resistance ( LTP > R1)
Benjamin Graham Value Screen
Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
Relative Outperformance versus Industry over 1 Year
Relative Outperformance versus Industry over 1 Month
Overbought by Money Flow Index (MFI)
Companies with Low Debt
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
RSI indicating price strength
High Volume, High Gain
Top Gainers
Volume Shockers
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| No Record Found | ||||
Financials | |||||
|---|---|---|---|---|---|
| Price (₹) | ₹1,431.80 | ₹2,045 | ₹162 | ₹1,803 | ₹1,014.60 |
| % Change | -0.42% | 1.02% | 0.92% | -1.03% | -0.43% |
| Revenue TTM (₹ Cr) | ₹8,850.08 | ₹13,914.08 | ₹8,871.37 | ₹6,112.77 | ₹6,721.63 |
| Net Profit TTM (₹ Cr) | ₹869.92 | ₹1,779.35 | ₹-163.61 | ₹847.18 | ₹843.32 |
| PE TTM | 31.30 | 47.50 | -131.70 | 35.10 | 65.10 |
| 1 Year Return | 44.17 | -12.08 | -22.44 | 18.09 | 95.04 |
| ROCE | 20.80 | 13.27 | 6.40 | 11.43 | 11.82 |
Alkem Laboratories Ltd.
₹ 5487.00
+1.76%
Biocon Ltd.
₹ 388.00
+1.05%
Divi's Laboratories Ltd.
₹ 6258.50
-0.52%
Ajanta Pharma Ltd.
₹ 2975.00
+1.21%
Zydus Lifesciences Ltd.
₹ 905.30
-
Glenmark Pharmaceuticals Ltd.
₹ 2033.00
-0.50%
Wockhardt Ltd.
₹ 1370.00
-0.84%
Aurobindo Pharma Ltd.
₹ 1148.70
-0.87%
Sun Pharmaceutical Industries Ltd.
₹ 1732.00
+0.44%
Ipca Laboratories Ltd.
₹ 1469.70
+1.37%
J B Chemicals & Pharmaceuticals Ltd.
₹ 2051.00
+2.53%
AstraZeneca Pharma India Ltd.
₹ 8807.00
-0.93%
GlaxoSmithKline Pharmaceuticals Ltd.
₹ 2635.30
+1.48%
Pfizer Ltd.
₹ 5066.60
+2.74%
Abbott India Ltd.
₹ 26425.00
+0.49%
Torrent Pharmaceuticals Ltd.
₹ 4318.50
+1.81%
Lupin Ltd.
₹ 2241.00
+0.97%
Dr. Reddy's Laboratories Ltd.
₹ 1305.10
+1.93%
Cipla Ltd.
₹ 1327.00
-1.05%
By signing up I certify terms, conditions & privacy policy